SENSEX NIFTY

Indian Pharma

Feb 23, 2017 at 22:00 | Source: CNBC-TV18
There's no end in sight for the Indian pharmaceutical industry's struggles with domestic and foreign drug regulators. It's true that quite a few companies have received clean chits from regulators in the US, UK and Europe. However, at the same time, new issues have also been cropping up with disturbing frequency.
Feb 23, 2017 at 21:27 | Source: Moneycontrol.com
Data reliability or data integrity are often linked to allegations of data falsification or manipulation, which are cited as main reasons by US FDA for pulling up Indian companies as part of its regulatory scrutiny.
Feb 23, 2017 at 13:39 | Source: Moneycontrol.com
Easing regulatory concerns and actions by the US Food and Drug Administration (FDA) will help the sector and improve investor sentiment, Deutsche Bank said in a report.
Feb 21, 2017 at 09:48 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com recommends buying Escorts, Biocon, Vedanta, South Indian Bank and Natco Pharma.
Feb 20, 2017 at 08:26 | Source: CNBC-TV18
Idea Cellular | Axis Bank | Kotak Mahindra Bank | Hindustan Unilever | McNally Bharat | Havells | BPCL | GPT Infra | Mangalam Drugs and GSK Pharma are stocks, which are in the news today.
Feb 16, 2017 at 08:54 | Source: PTI
The Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, approved award of 31 fields out of the 34 that had received bids.
Feb 16, 2017 at 08:00 | Source: CNBC-TV18
SBI | TCS | Sun Pharma | Tata Steel | Cipla | Hindalco Industries | Petronet LNG | State Bank of Bikaner and Jaipur | State Bank of Mysore | State Bank of Travancore | Cyient | Reliance Defence and Bharat Forge are stocks, which are in the news today.
Feb 11, 2017 at 14:48 | Source: Moneycontrol.com
Mild correction may be seen in the week ahead as the market seems to have priced in earnings that were not affected by the note ban in November, even as the results of state Assembly elections are keenly awaited.
Feb 10, 2017 at 14:55 | Source: Moneycontrol.com
The 2016 Special 301 Report continued with the placement of India on the PWL despite noting several positives that have contributed to a better environment for the protection and enforcement of intellectual property rights in India.
Feb 09, 2017 at 19:52 | Source: PTI
The Competition Commission hasdismissed allegations of abuse of dominance againstFranco-Indian Pharmaceuticals with respect to supply ofmedicines.
Messages on Indian Pharma »

News Flash

Platinum Member

1381 Followers

Just Posted  

Cipla CEO To CNBC-TV18 : It Will Be Reactionary But Indian Pharma Will Do All To Maximise In US

8.30 PM Feb 23rd

News Flash

Platinum Member

1381 Followers

Just Posted  

Cipla CEO To CNBC-TV18 : It Will Be Reactionary But Indian Pharma Will Do All To Maximise In US

3.45 PM Feb 23rd

News Flash

Platinum Member

1381 Followers

Just Posted  

Cipla CEO To CNBC-TV18 : It Will Be Reactionary But Indian Pharma Will Do All To Maximise In US

3.30 PM Feb 23rd

News Flash

Platinum Member

1381 Followers

Just Posted  

Cipla CEO To CNBC-TV18 : It Will Be Reactionary But Indian Pharma Will Do All To Maximise In US

3.15 PM Feb 23rd

ashish88820
01

New Member

0 Follower

Aurobindo Pharm  

Drug regulation Bill in USA may affect Indian pharma sector

10.21 AM Feb 23rd

sincereadvi
ser

New Member

4 Followers

Aurobindo Pharm  

Few shorters are posting misleading msgs & wrong info, USA dependency on indian pharmaceuticals will always remain & they cant afford to cut short import just because of Trump The Joker`s comments.....china`s supply can be impacted but in that case indian pharma companies are going to be the most

5.50 PM Feb 22nd

live-market

New Member

198 Followers

Sun Pharma  

DILIPJI IS BRAVE FACE OF INDIAN PHARMA INDUSTRIES AND PEOPLE WILL SEE JUST WAIT AND WATCH.......DESPITE HALOL AND RANBAXY ISSUE COMPANY IS POSTING VERY GOOD SET OFF NOS.....AND NOW ONWARDS RUSSIA ACQUISITION AS WELL USA ACQUISITION BESIDE HALOL PRODUCT SHIFT WILL START COMING IN.....DOMESTIC MARKET

12.00 PM Feb 15th

winner-firs
t

New Member

6 Followers

Sun Pharma  

A VERY POSITIVE FOR ANY INDIAN PHARMA COMPANY AS WELL AS BIG MILESTONE AND IAGE MAKEOVER FOR SUN

10.54 AM Feb 15th

cpmc

Silver Member

43 Followers

Natco Pharma  

True that. Share the thoughts aired here. This space has been by the Indian Pharma companies over the years with investment in facilities and development of products over the years - as also people being groomed to run these setups. China has always been much ahead than India on the API front

9.34 PM Feb 10th

nathanja1

New Member

10 Followers

Natco Pharma  

Rather than begging USA Indian pharma companies can just stop pharma exports for 3 months and then see how US companies beg for our drugs. The US and the entire world now depend on Indian pharma for generics and APIs. Without Indian pharma, woldwide drug prices will shoot. We have to educate the US

6.11 PM Feb 10th

News across the web »
Jun 24, 2016 at 15:20 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.